Protective role of exogenous recombinant peroxiredoxin 6 under ischemia-reperfusion injury of kidney

  • R. G. Goncharov
  • K. A. Rogov
  • A. A. Temnov
  • V. I. Novoselov
  • M. G. SharapovEmail author
Regular Article


Peroxiredoxin 6 (Prx6) is an important antioxidant enzyme with various functions in the cell. Prx6 reduces a wide range of peroxide substrates, playing a leading role in maintaining the redox homeostasis of mammalian cells. In addition to the peroxidase activity, a phospholipase A2-like activity was demonstrated for Prx6, which plays an important role in the metabolism of membrane phospholipids. Besides that, due to its peroxidase and phospholipase activities, Prx6 participates in intracellular and intercellular signal transduction, thus triggering regenerative processes in the cell, suppressing apoptosis caused by various factors, including ischemia-reperfusion injuries. A nephroprotective effect of exogenous recombinant Prx6 administered before ischemia-reperfusion injury was demonstrated on an animal model. Exogenous Prx6 effectively alleviates the severeness of renal ischemia-reperfusion injuries and facilitates normalization of their structural and functional conditions. Infusion of exogenous Prx6 increases the survival rate of experimental animals by almost 3 times. Application of exogenous Prx6 can be an effective approach in the prevention and treatment of renal ischemia-reperfusion kidney lesions and in preserving isolated kidneys during transplantation.


Peroxiredoxin 6 Oxidative stress Kidney Ischemia-reperfusion injury 



This work was supported by the Russian Foundation for Basic Research (grant nos. 17-04-00356-a and 19-04-00080-a) and the “Molecular and Cell Biology” program of the Presidium of the Russian Academy of Sciences.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving animals

The study protocol was approved by the institutional Ethics Committee of Institute of Cell Biophysics RAS and all experiments were carried out according to international regulations listed in the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes (ETS 123) and ICB RAS Manual for Working with Laboratory Animal no. 57 (30.12.2011).

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. Acarin L, González B, Castellano B (2000) Oral administration of the anti-inflammatory substance triflusal results in the downregulation of constitutive transcription factor NF-kappaB in the postnatal rat brain. Neurosci Lett 288:41–44. CrossRefPubMedGoogle Scholar
  2. Aminzadeh MA, Nicholas SB, Norris KC, Vaziri ND (2013) Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy. Nephrol Dial Transplant 28:2038–2045. CrossRefPubMedPubMedCentralGoogle Scholar
  3. Baum N, Dichoso CC, Carlton CE (1975) Blood urea nitrogen and serum creatinine. Urology 5:583–588. CrossRefPubMedGoogle Scholar
  4. Bienert GP, Møller AL, Kristiansen KA, Schulz A, Møller IM, Schjoerring JK, Jahn TP (2007) Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J Biol Chem. 282:1183–1192.
  5. Biet F, Locht C, Kremer L (2002) Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med 80:147–162. CrossRefPubMedGoogle Scholar
  6. Bonventre JV (2014) Kidney injury molecule-1: a translational journey. TransAm Clin Climatolog Assoc 125:293–299Google Scholar
  7. Chowhan R, Rajendrakumar Singh L, Nongdam P, Meetei P, Shahnaj S, Kakchingtabam P, Fisher A, Herojit Singh K, Rahaman H (2019) Hyperoxidation of peroxiredoxin 6 induces alteration from dimeric to oligomeric state. Antioxidants 8:33. CrossRefPubMedCentralGoogle Scholar
  8. Eismann T, Huber N, Shin T, Kuboki S, Galloway E, Wyder M, Edwards MJ, Greis KD, Shertzer HG, Fisher AB, Lentsch AB (2009) Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice. Am J Physiol Gastrointest Liver Physiol 296:G266–G274. CrossRefPubMedGoogle Scholar
  9. Eltzschig HK, Eckle T (2011) Ischemia and reperfusion—from mechanism to translation. Nat Med 17:1391–1401. CrossRefPubMedGoogle Scholar
  10. Feldman N, Rotter-Maskowitz A, Okun E (2015) DAMPs as mediators of sterile inflammation in aging-related pathologies. Ageing Res Rev. 24:29–39.
  11. Fisher AB (2018) The phospholipase A 2 activity of peroxiredoxin 6. J Lipid Res 59:1132–1147. CrossRefPubMedPubMedCentralGoogle Scholar
  12. Fisher AB (2017) Peroxiredoxin 6 in the repair of peroxidized cell membranes and cell signaling. Arch Biochem Biophys 617:68–83. CrossRefPubMedGoogle Scholar
  13. Fisher AB, Vasquez-Medina JP, Dodia C, Sorokina EM, Tao J-Q, Feinstein SI (2018) Peroxiredoxin 6 phospholipid hydroperoxidase activity in the repair of peroxidized cell membranes. Redox Biol 14:41–46. CrossRefPubMedGoogle Scholar
  14. Godoy JR, Oesteritz S, Hanschmann EM, Ockenga W, Ackermann W, Lillig CH (2011) Segment-specific overexpression of redoxins after renal ischemia and reperfusion: protective roles of glutaredoxin 2, peroxiredoxin 3, and peroxiredoxin 6. Free Radic Biol Med 51:552–561. CrossRefPubMedGoogle Scholar
  15. Gordeeva AE, Temnov AA, Charnagalov AA, Sharapov MG, Fesenko EE, Novoselov VI (2015) Protective effect of peroxiredoxin 6 in ischemia/reperfusion-induced damage of small intestine. Dig Dis Sci 60:3610–3619. CrossRefPubMedGoogle Scholar
  16. Gowda S, Desai PB, Kulkarni SS, Hull VV, Math AAK, Vernekar SN (2010) Markers of renal function tests. N Am J Med Sci 2:170–173PubMedPubMedCentralGoogle Scholar
  17. Granger DN, Kvietys PR (2015) Reperfusion injury and reactive oxygen species: the evolution of a concept. Redox Biol 6:524–551. CrossRefPubMedPubMedCentralGoogle Scholar
  18. Haga Y, Ohtsubo T, Murakami N, Noguchi H, Kansui Y, Goto K, Matsumura K, Kitazono T (2017) Disruption of xanthine oxidoreductase gene attenuates renal ischemia reperfusion injury in mice. Life Sci. 182:73–79.
  19. Hanschmann E-M, Godoy JR, Berndt C, Hudemann C, Lillig CH (2013) Thioredoxins, glutaredoxins, and peroxiredoxins—molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. Antioxid Redox Signal 19:1539–1605. CrossRefPubMedPubMedCentralGoogle Scholar
  20. Hellweg CE (2015) The Nuclear Factor κB pathway: A link to the immune system in the radiation response. Cancer Lett. 368:275–289.
  21. Hesketh EE, Czopek A, Clay M, Borthwick G, Ferenbach D, Kluth D, Hughes J (2014) Renal ischaemia reperfusion injury: a mouse model of injury and regeneration. J Vis Exp : JoVE 15:e51816. CrossRefGoogle Scholar
  22. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK (2004) Distinct Subcellular Localizations of Nox1 and Nox4 in Vascular Smooth Muscle Cells. Arterioscler Thromb Vasc Biol. 24:677–683.
  23. Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, Bihorac A (2009) Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 119:2444–2453. CrossRefPubMedGoogle Scholar
  24. Ishii T (2015) Close teamwork between Nrf2 and peroxiredoxins 1 and 6 for the regulation of prostaglandin D2 and E2 production in macrophages in acute inflammation. Free Radic Biol Med 88:189–198. CrossRefPubMedGoogle Scholar
  25. Ishimura T, Fujisawa M, Isotani S, Iijima K, Yoshikawa N, Kamidono S (2002) Endothelial nitric oxide synthase expression in ischemia-reperfusion injury after living related-donor renal transplantation. TransplInt 15:635–640CrossRefGoogle Scholar
  26. Kalogeris T, Baines CP, Krenz M, Korthuis RJ (2012) Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol 298:229–317. CrossRefPubMedPubMedCentralGoogle Scholar
  27. Kang SW, Baines IC, Rhee SG (1998) Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J Biol Chem 273:6303–6311. CrossRefPubMedGoogle Scholar
  28. Karplus PA, Hall A (2007) Structural survey of the peroxiredoxins. Subcell Biochem 44:41–60CrossRefPubMedGoogle Scholar
  29. Kim KH, Lee W, Kim EEK (2016) Crystal structures of human peroxiredoxin 6 in different oxidation states. Biochem Biophys Res Commun 477:717–722. CrossRefPubMedGoogle Scholar
  30. Kim SY, Jo H-Y, Kim MH, Cha Y-Y, Choi SW, Shim J-H, Kim TJ, Lee K-Y (2008) H2O2-dependent hyperoxidation of peroxiredoxin 6 (Prdx6) plays a role in cellular toxicity via up-regulation of iPLA2 activity. J Biol Chem 283:33563–33568. CrossRefPubMedPubMedCentralGoogle Scholar
  31. Kuang X, Wang L-F, Yu L, Li Y-J, Wang Y-N, He Q, Chen C, Du J-R (2014) Ligustilide ameliorates neuroinflammation and brain injury in focal cerebral ischemia/reperfusion rats: involvement of inhibition of TLR4/peroxiredoxin 6 signaling. Free Radic Biol Med 71:165–175. CrossRefPubMedGoogle Scholar
  32. Kümin A, Huber C, Rülicke T, Wolf E, Werner S (2006) Peroxiredoxin 6 is a potent cytoprotective enzyme in the epidermis. Am J Pathol 169:1194–1205. CrossRefPubMedPubMedCentralGoogle Scholar
  33. Maksimenko AV (2016) Widening and elaboration of consecutive research into therapeutic antioxidant enzyme derivatives. Oxidative Med Cell Longev 2016:1–9. CrossRefGoogle Scholar
  34. Maksimenko AV, Vavaev AV (2012) Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzyme antioxidants: the next stage of pharmacological counterwork to the oxidative stress. Heart Int 7:7. CrossRefGoogle Scholar
  35. Manevich Y, Fisher AB (2005) Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radic Biol Med 38:1422–1432. CrossRefPubMedGoogle Scholar
  36. Morgan MJ, Liu Z (2011) Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res 21:103–115. CrossRefPubMedGoogle Scholar
  37. Novoselov SV, Peshenko IV, Popov VI, Novoselov VI, Bystrova MF, Evdokimov VJ, Kamzalov SS, Merkulova MI, Shuvaeva TM, Lipkin VM, Fesenko EE (1999) Localization of 28-kDa peroxiredoxin in rat epithelial tissues and its antioxidant properties. Cell Tissue Res 298:471–480. CrossRefPubMedGoogle Scholar
  38. Palayoor ST, Youmell MY, Calderwood SK, Coleman CN, Price BD (1999) Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen. Oncogene 18:7389–7394. CrossRefPubMedGoogle Scholar
  39. Park KM, Byun JY, Kramers C, Kim JI, Huang PL, Bonventre JV (2003) Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 278:27256–27266. CrossRefPubMedGoogle Scholar
  40. Perkins A, Poole LB, Karplus PA (2014) Tuning of peroxiredoxin catalysis for various physiological roles. Biochemistry 53:7693–7705. CrossRefPubMedPubMedCentralGoogle Scholar
  41. Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30:e36.
  42. Pires BRB, Silva RCMC, Ferreira GM, Abdelhay E (2018) NF-kappaB: two sides of the same coin. Genes 9:E24. CrossRefPubMedGoogle Scholar
  43. Reuther-Madrid JY, Kashatus D, Chen S, Li X, Westwick J, Davis RJ, Earp HS, Wang C-Y, Baldwin AS Jr (2002) The p65/RelA subunit of NF-kappaB suppresses the sustained, antiapoptotic activity of Jun kinase induced by tumor necrosis factor. Mol Cell Biol 22:8175–8183. CrossRefPubMedPubMedCentralGoogle Scholar
  44. Rhee SG (2016) Overview on peroxiredoxin. Mol Cell 39:1–5. CrossRefGoogle Scholar
  45. Riddell JR, Maier P, Sass SN, Moser MT, Foster BA, Gollnick SO (2012) Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α. PloS one 7:e50394.
  46. Rosenblum ND (2013) Kidney development. In: National Kidney Foundation’s Primer on Kidney Diseases, Sixth Edition. pp 19–25Google Scholar
  47. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011) The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta Mol Cell Res 1813:878–888. CrossRefGoogle Scholar
  48. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3:1101–1108. CrossRefPubMedGoogle Scholar
  49. Sharapov MG, Gordeeva AE, Goncharov RG, Tikhonova IV, Ravin VK, Temnov AA, Fesenko EE, Novoselov VI (2017a) The effect of exogenous peroxiredoxin 6 on the state of mesenteric vessels and the small intestine in ischemia–reperfusion injury. Biophysics 62:998–1008. CrossRefGoogle Scholar
  50. Sharapov MG, Gudkov SV, Gordeeva AE, Karp OE, Ivanov VE, Shelkovskaya OV, Bruskov VI, Novoselov VI, Fesenko EE (2016) Peroxiredoxin 6 is a natural radioprotector. Dokl Biochem Biophys 467:110–112. CrossRefPubMedGoogle Scholar
  51. Sharapov MG, Novoselov VI, Fesenko EE, Bruskov VI, Gudkov SV (2017b) The role of peroxiredoxin 6 in neutralization of X-ray mediated oxidative stress: effects on gene expression, preservation of radiosensitive tissues and postradiation survival of animals. Free Radic Res 51:148–166. CrossRefPubMedGoogle Scholar
  52. Sharapov MG, Novoselov VI, Gudkov SV (2019) Radioprotective role of peroxiredoxin 6. Antioxidants 8:1–23. CrossRefGoogle Scholar
  53. Sharapov MG, Novoselov VI, Ravin VK (2009) The cloning, expression, and comparative analysis of peroxiredoxin 6 from various sources. Mol Biol 43:465–471. CrossRefGoogle Scholar
  54. Sharapov MG, Penkov NV, Gudkov SV, Goncharov RG (2018) The role of intermolecular disulfide bonds in stabilizing the structure of peroxiredoxins. Biophysics 63:154–161. CrossRefGoogle Scholar
  55. Sharapov MG, Ravin VK, Novoselov VI (2014) Peroxiredoxins as multifunctional enzymes. Mol Biol 48:520–545. CrossRefGoogle Scholar
  56. Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131–E136. CrossRefPubMedGoogle Scholar
  57. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O (1996) Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 93:13176–13181. CrossRefPubMedPubMedCentralGoogle Scholar
  58. Shichita T, Hasegawa E, Kimura A, Morita R, Sakaguchi R, Takada I, Sekiya T, Ooboshi H, Kitazono T, Yanagawa T, Ishii T, Takahashi H, Mori S, Nishibori M, Kuroda K, Akira S, Miyake K, Yoshimura A (2012) Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat Med.18:911–7.
  59. Sorrell SL, Golder ZJ, Johnstone DB, Karet Frankl FE (2015) Renal peroxiredoxin 6 interacts with anion exchanger 1 and plays a novel role in pH homeostasis. Kidney Int 89:105–112. CrossRefGoogle Scholar
  60. Staal FJ, Roederer M, Herzenberg LA (1990) Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A 87:9943–9947CrossRefPubMedPubMedCentralGoogle Scholar
  61. Tornroth-Horsefield S, Hedfalk K, Fischer G, Lindkvist-Petersson K, Neutze R. (2010) Structural insights into eukaryotic aquaporin regulation. FEBS Lett. 584:2580–2588.
  62. Tulsawani R, Kelly LS, Fatma N, Chhunchha B, Kubo E, Kumar A, Singh DP (2010) Neuroprotective effect of peroxiredoxin 6 against hypoxia-induced retinal ganglion cell damage. BMC Neurosci 11:125. CrossRefPubMedPubMedCentralGoogle Scholar
  63. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators (2005) Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294:813–818. CrossRefPubMedGoogle Scholar
  64. Veal EA, Underwood ZE, Tomalin LE, Morgan BA, Ché S (2017) Hyperoxidation of peroxiredoxins: gain or loss of function? Antioxid Redox Signal 28(7):574–590 7625. CrossRefPubMedGoogle Scholar
  65. Vénéreau E, Ceriotti C, Bianchi ME (2015) DAMPs from Cell Death to New Life. Front Immunol. 6:422.
  66. Vickers S, Schiller HJ, Hildreth JEK, Bulkley GB (1998) Immunoaffinity localization of the enzyme xanthine oxidase on the outside surface of the endothelial cell plasma membrane. Surgery 124:551–560.
  67. Volkova AG, Sharapov MG, Ravin VK, Gordeeva AE, Karaduleva EV, Mubarakshina EK, Temnov AA, Fesenko EE, Novoselov VI (2014) Effects of different antioxidant enzymes on the tracheal epithelium regeneration after chemical burn. Russian Pulmonol 6:84–90. CrossRefGoogle Scholar
  68. Waikar SS, Liu KD, Chertow GM (2008) Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol 3:844–861. CrossRefPubMedGoogle Scholar
  69. Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, Ray JG, University of Toronto Acute Kidney Injury Research Group (2009) Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302:1179–1185. CrossRefPubMedGoogle Scholar
  70. Wang T, Zhang X, Li JJ (2002) The role of NF-kappaB in the regulation of cell stress responses. Int Immunopharmacol 2:1509–1520. CrossRefPubMedGoogle Scholar
  71. Wang X, Phelan SA, Forsman-Semb K, Taylor EF, Petros C, Brown A, Lerner CP, Paigen B (2003) Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress. J Biol Chem 278:25179–25190. CrossRefPubMedGoogle Scholar
  72. Wang Y, Feinstein SI, Fisher AB (2008) Peroxiredoxin 6 as an antioxidant enzyme: protection of lung alveolar epithelial type II cells from H2O2-induced oxidative stress. J Cell Biochem 104:1274–1285. CrossRefPubMedPubMedCentralGoogle Scholar
  73. Wei Q, Dong Z (2012) Mouse model of ischemic acute kidney injury: technical notes and tricks. Am J Physiol Ren Physiol 303:F1487–F1494. CrossRefGoogle Scholar
  74. Williams P, Lopez H, Britt D, Chan C, Ezrin A, Hottendorf R (1997) Characterization of renal ischemia-reperfusion injury in rats. J Pharmacol Toxicol Methods 37:1–7CrossRefPubMedGoogle Scholar
  75. Wood ZA, Poole LB, Karplus PA (2003) Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300:650–653. CrossRefPubMedGoogle Scholar
  76. Yamamoto Y, Yin MJ, Lin KM, Gaynor RB (1999) Sulindac inhibits activation of the NF-kappaB pathway. J Biol Chem 274:27307–27314. CrossRefPubMedGoogle Scholar
  77. Yu TM, Palanisamy K, Sun KT, Day YJ, Shu KH, Wang IK, Shyu WC, Chen P, Chen YL, Li CY (2016) RANTES mediates kidney ischemia reperfusion injury through a possible role of HIF-1α and LncRNA PRINS. Sci Rep 6:1–11. CrossRefGoogle Scholar
  78. Zhang L, Wang K, Lei Y, Li Q, Nice EC, Huang C (2015) Redox signaling: potential arbitrator of autophagy and apoptosis in therapeutic response. Free Radic Biol Med 89:452–465. CrossRefPubMedGoogle Scholar
  79. Zhang S, Wang W, Gu Q, Xue J, Cao H, Tang Y, Xu X, Cao J, Zhou J, Wu J, Ding W-QQ (2014) Protein and miRNA profiling of radiation-induced skin injury in rats: the protective role of peroxiredoxin-6 against ionizing radiation. Free Radic Biol Med 69:96–107. CrossRefPubMedGoogle Scholar
  80. Zhou S, Lien YC, Shuvaeva T, Debolt K, Feinstein SI, Fisher AB (2013) Functional interaction of glutathione S-transferase pi and peroxiredoxin 6 in intact cells. Int J Biochem Cell Biol 45:401–407. CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Institute of Cell Biophysics of the Russian Academy of SciencesPSCBR RASPushchinoRussia
  2. 2.Research Institute of Human MorphologyMoscowRussia
  3. 3.Faculty of Biological and Medical PhysicsMoscow Institute of Physics and Technology (MIPT)DolgoprudnyRussia

Personalised recommendations